|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 396.65 INR | +4.18% |
|
+2.18% | +27.79% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 367M 322M 301M 276M 516M 529M 3.56B 1.39B 17.37B 1.38B 1.35B 60.05B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 395M 347M 324M 297M 556M 570M 3.84B 1.5B 18.7B 1.48B 1.45B 64.66B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
23.47% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +4.18% | ||
| 1 week | +2.18% | ||
| Current month | -3.85% | ||
| 1 month | +5.34% | ||
| 3 months | +1.64% | ||
| 6 months | +30.89% | ||
| Current year | +27.79% |
| 1 week | 378.3 |  | 398.75 |
| 1 month | 378 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 111.85 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 29/08/1990 | |
| Director of Finance/CFO | - | 12/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 29/08/1990 | |
| Director/Board Member | 37 | 04/06/2020 | |
| Director/Board Member | 48 | 28/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.18% | +2.18% | +64.82% | +240.33% | 373M | |
| +0.67% | +1.43% | +16.90% | +74.77% | 49.64B | |
| +1.05% | +3.84% | +64.12% | +113.57% | 36.54B | |
| +2.06% | +2.92% | -6.22% | +25.17% | 12.22B | |
| +2.14% | -1.78% | +14.55% | +75.28% | 11.48B | |
| +1.05% | +1.16% | +31.33% | +131.86% | 9.04B | |
| +3.08% | +3.94% | +50.54% | -4.41% | 6.94B | |
| +0.17% | -0.34% | +12.61% | +31.76% | 6.74B | |
| +3.53% | +0.87% | +5.47% | +183.15% | 6.45B | |
| +0.61% | -6.24% | -32.70% | -1.66% | 5.42B | |
| Average | +1.85% | -0.86% | +22.14% | +86.98% | 14.48B | |
| Weighted average by Cap. | +1.25% | +0.45% | +26.75% | +80.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 74.05M 65.07M 60.73M 55.74M 104M 107M 720M 282M 3.51B 278M 272M 12.13B | 7.83B 81.72M 71.81M 67.03M 61.51M 115M 118M 795M 311M 3.87B 307M 300M 13.39B |
| Net income | 498M 5.2M 4.57M 4.27M 3.92M 7.33M 7.51M 50.59M 19.79M 247M 19.53M 19.11M 852M | 691M 7.22M 6.34M 5.92M 5.43M 10.17M 10.42M 70.2M 27.45M 342M 27.1M 26.51M 1.18B |
| Net Debt | 2.45B 25.54M 22.44M 20.95M 19.23M 35.99M 36.88M 248M 97.15M 1.21B 95.9M 93.82M 4.19B | 2.69B 28.11M 24.7M 23.06M 21.16M 39.61M 40.59M 273M 107M 1.33B 106M 103M 4.61B |
Employees
1,470
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | ₹396.65 | +4.18% | 228,126 |
| 28/07/26 | ₹380.75 | -2.85% | 102,761 |
| 27/07/26 | ₹391.90 | +2.83% | 98,936 |
| 24/07/26 | ₹381.10 | -0.92% | 48,295 |
| 23/07/26 | ₹384.65 | -0.49% | 160,315 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
